Inspire Medical Systems Q1 2024 GAAP EPS $(0.34) Beats $(0.66) Estimate, Sales $164.01M Beat $161.44M Estimate
Portfolio Pulse from Benzinga Newsdesk
Inspire Medical Systems (NYSE:INSP) reported Q1 2024 earnings with a GAAP EPS of $(0.34), surpassing the $(0.66) estimate, and sales of $164.01M, exceeding the $161.44M estimate. This represents a 28.24% increase in sales compared to the same period last year.
May 07, 2024 | 8:11 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Inspire Medical Systems reported a significant earnings beat and sales increase in Q1 2024, indicating strong financial performance.
The substantial beat on both EPS and sales estimates, coupled with a significant year-over-year sales growth, suggests a strong financial health and operational efficiency. This performance is likely to instill investor confidence and could lead to a positive short-term price movement for INSP.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100